PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25351103-10	2015	Taken together, YH-306 is a candidate drug in preventing growth and metastasis of CRC by modulating FAK signalling pathway.	YH-306	16-22	protein tyrosine kinase 2	Homo sapiens	100-103	
25351103-0	2015	A novel synthetic small molecule YH-306 suppresses colorectal tumour growth and metastasis via FAK pathway.	YH-306	33-39	protein tyrosine kinase 2	Homo sapiens	95-98	
25351103-8	2015	YH-306 suppressed the activation of focal adhesion kinase (FAK), c-Src, paxillin, and phosphatidylinositol 3-kinases (PI3K), Rac1 and the expression of matrix metalloproteases (MMP) 2 and MMP9.	YH-306	0-6	protein tyrosine kinase 2	Homo sapiens	36-57	
25351103-8	2015	YH-306 suppressed the activation of focal adhesion kinase (FAK), c-Src, paxillin, and phosphatidylinositol 3-kinases (PI3K), Rac1 and the expression of matrix metalloproteases (MMP) 2 and MMP9.	YH-306	0-6	protein tyrosine kinase 2	Homo sapiens	59-62